Bioqual SG&A Expenses 2010-2024 | BIOQ

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Bioqual sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Bioqual sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$19.7B
Quest Diagnostics (DGX)	$16.9B
DaVita (DVA)	$12.1B
Encompass Health (EHC)	$9.5B
Chemed (CHE)	$7.9B
Elanco Animal Health (ELAN)	$5.8B
RadNet (RDNT)	$5.3B
Option Care Health (OPCH)	$3.8B
Amedisys (AMED)	$2.7B
LifeStance Health (LFST)	$2.7B
Addus HomeCare (ADUS)	$2.4B
Astrana Health (ASTH)	$2B
U.S Physical Therapy (USPH)	$1.4B
Pennant (PNTG)	$938M
Aveanna Healthcare Holdings (AVAH)	$873M
Atai Life Sciences (ATAI)	$200M
Daxor (DXR)	$39M
Ontrak (OTRK)	$6M
MEDIROM Healthcare Technologies (MRM)	$5M
IMAC Holdings (BACK)	$1M
Psychemedics (PMD)	$0M